Synthetic Analogue of Leu-Enkephalin Prevents Endothelial Dysfunction in vitro
The purpose of the study was to determine the efficacy of a synthetic leu-enkephalin stabilized analogue to prevent damage of endothelial cells monolayer in vitro caused by serum samples from septic shock patients.Materials and methods. The experiments were performed using the EaHy.926 endothelial c...
Saved in:
Main Authors: | O. A. Grebenchikov, A. M. Ovezov, Yu. V. Skripkin, T. S. Zabelina, O. N. Ulitkina, A. V. Lugovoy, A. S. Prikhodko, A. Yu. Ryzhkov, R. A. Zinovkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2018-05-01
|
Series: | Общая реаниматология |
Subjects: | |
Online Access: | https://www.reanimatology.com/rmt/article/view/1680 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Leu-Enkephalin Synthetic Analogue in Regulation of Systemic Inflammatory Response and Prevention of ARDS in Severe Combined Injury
by: A. Y. Ryzhkov, et al.
Published: (2024-04-01) -
Cytoprotective effect of non-opiate leu-enkephalin analogues against the background of ornithine decarboxylase inhibitor exposure
by: E. N. Sazonova, et al.
Published: (2025-01-01) -
The state of the nucleo-nucleolar apparatus of the mature albino rat males cardiomyocytes exposed to intrauterine hypoxia and neonatal administration of non-opiate analogues of leu-enkephalin
by: I. A. Gusev, et al.
Published: (2025-01-01) -
Synthetic Analogue of Leu-Enkephalin in COVID-19 (a Prospective Clinical Study)
by: M. A. Magomedov, et al.
Published: (2022-08-01) -
Comparative Analysis of Dalargin Pharmaceutical Substance Identification Methods
by: M. G. Shulzhenko, et al.
Published: (2020-08-01)